• Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on June 13, 2024 at 10:00 a.m. Central TimeRead more
  • Exela Technologies, Inc. to Host First Quarter 2024 Financial Results Conference CallRead more
  • Exela Technologies Holdings, Inc. Reports First Quarter 2024 ResultsRead more

Exela Technologies, Inc. Reports First Quarter 2023 Results

First Quarter Highlights

  • Revenue of $273.6 million, down 2.1% year-over-year (0.9% on a constant currency basis)
  • Net loss of $45.4 million
  • Gross profit(1) of $57.2M, up $9M sequentially and gross margin improved to 20.9%
  • Adjusted EBITDA of $34.7M
  • $64.9M new TCV and renewal of $43.3M TCV reflect strength of award-winning best-in-class solutions and services
  • Value enhancing initiatives: Project Neon, XBP Europe and Recapitalization of Debt progressing
  • Results of the Special Meeting of Shareholders to be announced by May 12, 2023

Conference call scheduled for May 11, 2023 at 9:00 AM ET

IRVING, Texas, May 11, 2023 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA, XELAP), a global business process automation (“BPA”) leader, announced today its financial results for first quarter ended March 31, 2023.

“Our financial results demonstrate improvement in some financial metrics. However, we continue to stay focused on further improvements in business performance and financial flexibility,” said Par Chadha Executive Chairman of Exela.

First Quarter Highlights

  • Revenue: Revenue for Q1 2023 was $273.6 million, a decline of 2.1% compared to $279.4 million in Q1 2022.
    • Revenue for the Information and Transaction Processing Solutions (“ITPS”) segment was $193.7 million, a decline of 5.5% year-over-year, primarily due to $3.2 million of currency translation from a strong dollar, transition revenue(2) and other customer losses.
    • Healthcare Solutions revenue was $63.0 million, an increase of 11.3% year-over-year, led by higher volumes from our existing healthcare customers.
    • Legal and Loss Prevention Services revenue was $16.9 million, a decrease of 20.4% year-over-year due to lower project based engagements.

  • Operating income/(loss): Operating loss for Q1 2023 was $6.9 million, compared with operating loss of $7.3 million in Q1 2022. The $0.4 million year over year improvement in operating loss of was due to higher gross profit and lower depreciation and amortization offset by higher selling, general and administrative expenses and related party expense.

  • Net Loss: Net loss for Q1 2023 was $47.5 million, compared with a net loss of $57.9 million in Q1 2022.
    • EBITDA(3): EBITDA for Q1 2023 was $18.0 million compared to $3.5 million in Q1 2022. EBITDA margin for Q1 2023 was 6.6% compared to 1.3% in Q1 2022.
    • Adjusted EBITDA(4): Adjusted EBITDA for Q1 2023 was $34.7 million, a decrease of 4% compared to $36.1 million in Q1 2022. Adjusted EBITDA margin for Q1 2023 was 12.7%, a decrease of 25 basis points from 12.9% in Q1 2022.

Capital Expenditures: Capital expenditures for Q1 2023 were 1.1% of revenue compared to 3.1% of revenue in Q1 2022


Below are the notes referenced above:
(1) Gross Profit is defined as revenue less cost of revenue excluding depreciation and amortization
(2) Transition revenue is attributable to exiting contracts and statements of work with certain customers that we believe was unpredictable, non-recurring and were not a strategic fit to Company’s long-term success or unlikely to achieve the Company’s long-term target margins.
(3) EBITDA is a non-GAAP measure. A reconciliation of EBITDA is attached to this release.
(4) Adjusted EBITDA is a non-GAAP measure. A reconciliation of Adjusted EBITDA is attached to this release.


Earnings Conference Call and Audio Webcast

Exela will host a conference call to discuss its first quarter 2023 financial results at 9:00 AM ET on May 11, 2023. To access this call, dial 833-255-2831 or +1-412-902-6724 (international). The password for the call is “Exela Earnings Call”.

Shortly after the conclusion of the call, a replay will be available through May 18, 2023 at 877-344-7529 or +1-412-317-0088 (international). The replay passcode is 8980704. A replay will also be archived on the Exela investor relations website at http://investors.exelatech.com.

Exela invites all investors to ask questions that they would like addressed on the conference call. We ask investors to submit questions via email to IR@exelatech.com.

A live webcast of this conference call will be available on the “Investors” page of the Company’s website (www.exelatech.com). A supplemental slide presentation that accompanies this call and webcast can be found on the investor relations website (http://investors.exelatech.com/) and will remain available after the call.  

About Exela 
Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of experience operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over 60% of the Fortune® 100. Utilizing foundational technologies spanning information management, workflow automation, and integrated communications, Exela’s software and services include multi-industry, departmental solution suites addressing finance and accounting, human capital management, and legal management, as well as industry-specific solutions for banking, healthcare, insurance, and the public sector. Through cloud-enabled platforms, built on a configurable stack of automation modules, and approximately 15,000 employees operating in 21 countries, Exela rapidly deploys integrated technology and operations as an end-to-end digital journey partner.

Find out more at www.exelatech.com

To automatically receive Exela financial news by e-mail, please visit the Exela Investor Relations website, http://investors.exelatech.com/, and subscribe to E-mail Alerts.

About Non-GAAP Financial Measures: This press release includes constant currency, EBITDA and Adjusted EBITDA, each of which is a financial measure that is not prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Exela believes that the presentation of these non-GAAP financial measures will provide useful information to investors in assessing our financial performance, results of operations and liquidity and allows investors to better understand the trends in our business and to better understand and compare our results. Exela’s board of directors and management use constant currency, EBITDA and Adjusted EBITDA to assess Exela’s financial performance, because it allows them to compare Exela’s operating performance on a consistent basis across periods by removing the effects of Exela’s capital structure (such as varying levels of debt and interest expense, as well as transaction costs resulting from the combination of Quinpario Acquisition Corp. 2, SourceHOV Holdings, Inc. and Novitex Holdings, Inc. on July 12, 2017 (the “Novitex Business Combination”) and capital markets-based activities). Adjusted EBITDA also seeks to remove the effects of integration and related costs to achieve the savings, any expected reduction in operating expenses due to the Novitex Business Combination, asset base (such as depreciation and amortization) and other similar non-routine items outside the control of our management team.  Optimization and restructuring expenses and merger adjustments are primarily related to the implementation of strategic actions and initiatives related to the Novitex Business Combination. All of these costs are variable and dependent upon the nature of the actions being implemented and can vary significantly driven by business needs. Accordingly, due to that significant variability, we exclude these charges since we do not believe they truly reflect our past, current or future operating performance. The constant currency presentation excludes the impact of fluctuations in foreign currency exchange rates. We calculate constant currency revenue and Adjusted EBITDA on a constant currency basis by converting our current-period local currency financial results using the exchange rates from the corresponding prior-period and compare these adjusted amounts to our corresponding prior period reported results. Exela does not consider these non-GAAP measures in isolation or as an alternative to liquidity or financial measures determined in accordance with GAAP. A limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in Exela’s financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and income are excluded or included in determining these non-GAAP financial measures and therefore the basis of presentation for these measures may not be comparable to similarly-titled measures used by other companies. These non-GAAP financial measures are not required to be uniformly applied, are not audited and should not be considered in isolation or as substitutes for results prepared in accordance with GAAP. Net loss is the GAAP measure most directly comparable to the non-GAAP measures presented here. For reconciliation of the comparable GAAP measures to these non-GAAP financial measures, see the schedules attached to this release.

Forward-Looking Statements: Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for Exela, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties, including without limitation the network outage described in this press release and those discussed under the heading “Risk Factors” in our Annual Report and in subsequent filings with the U.S. Securities and Exchange Commission (“SEC”). In addition, forward-looking statements provide Exela’s expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela’s assessments to change. These forward-looking statements should not be relied upon as representing Exela’s assessments as of any date subsequent to the date of this press release.

For more Exela news, commentary, and industry perspectives, visit:

Website: https://investors.exelatech.com/

Twitter: @ExelaTech

LinkedIn: /exela-technologies

Facebook: @exelatechnologies

Instagram: @exelatechnologies

The information posted on the Company's website and/or via its social media accounts may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its social media accounts in addition to the Company's press releases, SEC filings and public conference calls and webcasts.

Investor and/or Media Contacts:
Vincent Kondaveeti
E: vincent.kondaveeti@exelatech.com

Mary Beth Benjamin
E: IR@exelatech.com

Source: Exela Technologies, Inc.


Exela Technologies, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
As of March 31, 2023 and December 31, 2022
(in thousands of United States dollars except share and per share amounts)
               
    March 31,   December 31,  
    2023     2022    
    (Unaudited)   (Audited)  
Assets              
Current assets              
Cash and cash equivalents   $ 9,908     $ 15,073    
Restricted cash     40,911       29,994    
Accounts receivable, net of allowance for credit losses of $8,263 and $6,402, respectively     99,322       101,616    
Related party receivables and prepaid expenses     741       759    
Inventories, net     16,913       16,848    
Prepaid expenses and other current assets     28,020       26,206    
Total current assets     195,815       190,496    
Property, plant and equipment, net of accumulated depreciation of $213,178 and $207,520, respectively     68,518       71,694    
Operating lease right-of-use assets, net     40,109       40,734    
Goodwill     186,877       186,802    
Intangible assets, net     191,121       200,982    
Deferred income tax assets     1,578       1,483    
Other noncurrent assets     29,084       29,721    
Total assets   $ 713,102     $ 721,912    
               
Liabilities and Stockholders' Equity (Deficit)              
Liabilities              
Current liabilities              
Accounts payable   $ 72,047     $ 79,249    
Related party payables     2,548       2,473    
Income tax payable     421       2,045    
Accrued liabilities     63,459       61,340    
Accrued compensation and benefits     51,134       54,143    
Accrued interest     31,629       60,901    
Customer deposits     19,090       16,955    
Deferred revenue     18,278       16,405    
Obligation for claim payment     58,413       44,380    
Current portion of finance lease liabilities     5,167       5,485    
Current portion of operating lease liabilities     11,373       11,867    
Current portion of long-term debts     136,696       154,802    
Total current liabilities     470,255       510,045    
Long-term debt, net of current maturities     953,432       942,035    
Finance lease liabilities, net of current portion     9,055       9,448    
Pension liabilities, net     17,098       16,917    
Deferred income tax liabilities     11,702       11,180    
Long-term income tax liabilities     2,809       2,742    
Operating lease liabilities, net of current portion     30,663       31,030    
Other long-term liabilities     6,168       6,104    
Total liabilities     1,501,182       1,529,501    
Commitments and Contingencies (Note 8)              
Stockholders' equity (deficit)              
Common Stock, par value of $0.0001 per share; 1,600,000,000 shares authorized; 1,274,326,639 shares issued and 1,274,204,054 shares outstanding at March 31, 2023 and 278,777,820 shares issued and 278,655,235 shares outstanding at December 31, 2022     261       162    
Preferred stock, $0.0001 par value per share, 20,000,000 shares authorized at March 31, 2023 and December 31, 2022, respectively              
Series A Preferred Stock, 2,778,111 shares issued and outstanding at March 31, 2023 and December 31, 2022     1       1    
Series B Preferred Stock, 3,029,900 shares issued and outstanding at March 31, 2023 and December 31, 2022      -        -    
Additional paid in capital     1,169,548       1,102,619    
Less: Common Stock held in treasury, at cost; 122,585 shares at March 31, 2023 and December 31, 2022     (10,949 )     (10,949 )  
Equity-based compensation     57,069       56,958    
Accumulated deficit     (1,993,445 )     (1,948,009 )  
Accumulated other comprehensive loss:              
Foreign currency translation adjustment     (6,893 )     (4,788 )  
Unrealized pension actuarial losses, net of tax     (3,672 )     (3,583 )  
Total accumulated other comprehensive loss     (10,565 )     (8,371 )  
Total stockholders' deficit     (788,080 )     (807,589 )  
Total liabilities and stockholders' deficit   $ 713,102     $ 721,912    


Exela Technologies, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
For the three months ended March 31, 2023 and 2022
(in thousands of United States dollars except share and per share amounts)
(Unaudited)
             
    Three Months Ended March 31,
    2023     2022  
Revenue   $ 273,620     $ 279,398  
Cost of revenue (exclusive of depreciation and amortization)     216,467       223,504  
Selling, general and administrative expenses (exclusive of depreciation and amortization)     44,381       43,040  
Depreciation and amortization     16,560       18,212  
Related party expense     3,112       1,987  
Operating profit (loss)     (6,900 )     (7,345 )
Other expense (income), net:            
Interest expense, net     44,180       39,760  
Debt modification and extinguishment costs (gain), net     (8,773 )     884  
Sundry expense, net     748       307  
Other expense (income), net     (282 )     6,159  
Net loss before income taxes     (42,773 )     (54,455 )
   Income tax expense     (2,663 )     (2,501 )
Net loss   $ (45,436 )   $ (56,956 )
Cumulative dividends for Series A Preferred Stock     (954 )     (864 )
Cumulative dividends for Series B Preferred Stock     (1,153 )     (75 )
Net loss attributable to common stockholders   $ (47,543 )   $ (57,895 )
Loss per share:            
Basic and diluted   $ (0.05 )   $ (3.37 )


Exela Technologies, Inc. and Subsidiaries
Condensed Consolidated Statement of Cash Flows
For the three months ended March 31, 2023 and 2022
(in thousands of United States dollars except share and per share amounts)
(Unaudited)
             
    Three Months Ended March 31
       2023       2022 
Cash flows from operating activities            
Net loss   $ (45,436 )   $ (56,956 )
Adjustments to reconcile net loss            
Depreciation and amortization     16,560       18,212  
Original issue discount and debt issuance cost amortization     7,456       3,531  
Debt modification and extinguishment costs (gain), net     (9,760 )     196  
Credit loss expense     1,983       61  
Deferred income tax provision     521       635  
Share-based compensation expense     111       308  
Unrealized foreign currency losses (gain)     238       (180 )
Loss (Gain) on sale of assets     88       (41 )
Change in operating assets and liabilities, net of effect from acquisitions            
Accounts receivable     950       (6,146 )
Prepaid expenses and other assets     (1,494 )     (8,858 )
Accounts payable and accrued liabilities     (24,232 )     5,345  
Related party payables     94       (12 )
Additions to outsource contract costs     (116 )     (140 )
Net cash used in operating activities     (53,037 )     (44,045 )
Cash flows from investing activities            
Purchase of property, plant and equipment     (1,888 )     (7,728 )
Additions to patents      -       (25 )
Additions to internally developed software     (1,014 )     (829 )
Proceeds from sale of assets      -       175  
Net cash used in investing activities     (2,902 )     (8,407 )
Cash flows from financing activities            
Proceeds from issuance of Common Stock from at the market offerings     69,260       119,196  
Cash paid for equity issuance costs from at the market offerings     (2,232 )     (4,664 )
Borrowings under factoring arrangement and Securitization Facility     31,985       35,837  
Principal repayment on borrowings under factoring arrangement and Securitization Facility     (31,325 )     (34,144 )
Cash paid for withholding taxes on vested RSUs      -       (195 )
Lease terminations      -       (15 )
Cash paid for debt issuance costs     (6,308 )     (5,615 )
Principal payments on finance lease obligations     (1,137 )     (1,516 )
Borrowings from senior secured revolving facility and BRCC revolver     9,600        -  
Repayments on senior secured revolving facility      -       (49,477 )
Proceeds from issuance of 2026 Notes      -       55,364  
Borrowings from other loans     12,152       1,865  
Cash paid for debt repurchases     (3,633 )      -  
Proceeds from Second Lien Note     31,500        -  
Repayment of BRCC term loan     (34,204 )     (22,675 )
Principal repayments on senior secured term loans and other loans     (14,107 )     (7,544 )
Net cash provided by financing activities     61,551       86,417  
Effect of exchange rates on cash     140       (50 )
Net increase in cash and cash equivalents     5,752       33,915  
Cash, restricted cash, and cash equivalents            
Beginning of period     45,067       48,060  
End of period   $ 50,819     $ 81,975  
Supplemental cash flow data:            
Income tax payments, net of refunds received   $ 1,147     $ 1,486  
Interest paid     65,300       9,941  
Noncash investing and financing activities:            
Assets acquired through right-of-use arrangements     405       50  
Accrued capital expenditures     1,945       1,483  

 

Exela Technologies
Schedule 1: First Quarter 2023 vs. Fourth Quarter 2022
Financial Performance
                 
$ in million Q1-2023 Q1-2022 Increase
(Decrease)
YoY ($ mn)
Increase
(Decrease)
YoY (%)
  Q4-2022 Increase
(Decrease)
QoQ ($ mn)
Increase
(Decrease)
QoQ (%)
                 
Information and Transaction Processing Solutions $ 193.7   $ 205.0   $ (11.3)   (5.5%)     $ 184.8   $ 8.9   4.8%  
Healthcare Solutions   63.0     56.6     6.4   11.3%       65.3     (2.3)   (3.5%)  
Legal and Loss Prevention Services   16.9     17.8     (0.9)   (5.1%)       16.8     0.1   0.6%  
Total Revenue $ 273.6   $ 279.4   $ (5.8)   -2.1%     $ 267.0   $ 6.7   2.5%  
                 
Gross profit   57.2     55.9     1.3   2.3%       48.1     9.1   18.8%  
Gross profit margin   20.9%     20.0%     0.9%   88 bps       18.0%     2.9%   287 bps  
                 
SG&A   44.4     43.0     1.3   3.1%       38.9     5.5   14.0%  
                 
Operating (loss) income   (6.9)     (7.3)     0.4   (6.1%)       (153.1)     146.2   (95.5%)  
Operating margin   (2.5%)     (2.6%)     0.1%   11 bps       (57.3%)     54.8%   5481 bps  
                 
Net income (loss)   (45.4)     (57.0)     11.5   (20.2%)       (194.1)     148.7   (76.6%)  
Net income margin   (16.6%)     (20.4%)     3.8%   378 bps       (72.7%)     56.1%   5612 bps  
                 
EBITDA   18.0     3.5     14.5   410.9%       (135.8)     153.8   (113.2%)  
EBITDA Margin   6.6%     1.3%     5.3%   531 bps       (50.9%)     57.4%   5745 bps  
                 
Adjusted EBITDA $ 34.7   $ 36.1   $ (1.4)   -4.0%     $ 35.5   $ (0.8)   -2.2%  
Adjusted EBITDA margin   12.7%     12.9%     (0.3%)   -25 bps       13.3%     (0.6%)   -61 bps  
                 


Exela Technologies
Schedule 2: Reconciliation of Adjusted EBITDA and constant currency revenues
 
Reconciliation of Non-GAAP Financial Measures to GAAP Measures        
             
             
Non-GAAP constant currency revenue reconciliation            
($ in millions)   Three months ended
  31-Mar-23   31-Mar-22   31-Dec-22
Revenues, as reported (GAAP)   $273.6     $279.4     $267.0  
Foreign currency exchange impact (1)     3.2           5.9  
Revenues, at constant currency (Non-GAAP)   $276.8     $279.4     $272.9  
             
(1) Constant currency excludes the impact of foreign currency fluctuations and is computed by applying the average exchange rates for the three months ended March 31, 2022, to the revenues during the corresponding period in 2023.
             
             
             
Reconciliation of Adjusted EBITDA            
($ in millions)   Three months ended
  31-Mar-23   31-Mar-22   31-Dec-22
Net loss (GAAP)   ($45.4)     ($57.0)     ($194.1)  
Interest expense     44.2       39.8       41.9  
Taxes     2.7       2.5       (1.5)  
Depreciation and amortization     16.6       18.2       17.9  
EBITDA (Non-GAAP)   $18.0     $3.5     ($135.8 )
Transaction and integration costs     5.2       3.7       2.1  
Gain / loss on derivative instruments     (0.1)       (0.0)       -  
Other Charges / (gains)     5.5       22.1       163.5  
Sub-Total (Adj. EBITDA before O&R)   $28.5     $29.3     $29.8  
Optimization and restructuring expenses     6.2       6.8       5.7  
Adjusted EBITDA (Non-GAAP)   $34.7     $36.1     $35.5  
             
(1) Constant currency excludes the impact of foreign currency fluctuations and is computed by applying the average exchange rates for the three months ended March 31, 2022, to the revenues during the corresponding period in 2023.
             

Primary Logo

Source: Exela Technologies, Inc.